Severe hemorrhagic colitis in a patient with chronic myeloid leukemia in the blastic phase after dasatinib use

Dasatinib is a second-line tyrosine kinase inhibitor used in patients with imatinib resistant or intolerant chronic myeloid leukemia (CML) and Philadelphia chromosome-positive acute leukemia. Gastrointestinal bleeding may occur in up to 7% of patients using dasatinib, although, severe dasatinib-rela...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Prif Awduron: Kmira, Zahra, Nesrine, Ben Sayed, Houneida, Zaghouani, Wafa, Ben Fredj, Aida, Slama, Yosra, Ben Youssef, Monia, Zaier, Sriha, Badreddine, Abderrahim, Khelif
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: Baishideng Publishing Group Co., Limited 2013
Pynciau:
Case Report
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC3740261/
https://ncbi.nlm.nih.gov/pubmed/23946889
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4291/wjgp.v4.i3.59
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg